Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180624040214N3Phase 3Completed
Phase 3, open-label trial of progesterone in female infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Rate of change in endometrial thickness and Chemical pregnancy rate. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180624040214N3.